| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.00033 | 1 |